02252.HK
Shanghai MicroPort MedBot (Group) Co., Ltd.
HKSE · Healthcare · Medical - Devices · CN
HKD 21.18
+0.00%Year over year
Reported trailing growth
- Revenue
- +114.2%
- EBITDA
- +75.6%
- EBIT
- +51.9%
- EPS
- +63.6%
- Free cash flow
- +90.1%
- Operating cash flow
- +89.6%
Forward estimates
Based on analyst estimates
- Revenue
- +14.6%
- EBITDA
- +294.6%
- EPS
- +108.8%
Three-year CAGR
- Revenue
- +194.4%
- EBITDA
- +76.6%
- EBIT
- +51.9%
- Net income
- +61.1%
- EPS
- +63.6%
- Free cash flow
- +88.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025